These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10922210)

  • 1. STOP-ROP results suggest selective use of supplemental oxygen for prethreshold ROP.
    Mills MD
    Arch Ophthalmol; 2000 Aug; 118(8):1121-2. PubMed ID: 10922210
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.
    McGregor ML; Bremer DL; Cole C; McClead RE; Phelps DL; Fellows RR; Oden N;
    Pediatrics; 2002 Sep; 110(3):540-4. PubMed ID: 12205257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.
    Pediatrics; 2000 Feb; 105(2):295-310. PubMed ID: 10654946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity.
    Gaynon MW; Stevenson DK; Sunshine P; Fleisher BE; Landers MB
    J Perinatol; 1997; 17(6):434-8. PubMed ID: 9447528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On "supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes".
    Flynn JT; Bancalari E
    J AAPOS; 2000 Apr; 4(2):65-6. PubMed ID: 10773803
    [No Abstract]   [Full Text] [Related]  

  • 6. Statistical issues related to early closure of STOP-ROP, a group-sequential trial.
    Oden NL; Phelps DL;
    Control Clin Trials; 2003 Feb; 24(1):28-38. PubMed ID: 12559640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity.
    Vanderveen DK; Mansfield TA; Eichenwald EC
    J AAPOS; 2006 Oct; 10(5):445-8. PubMed ID: 17070480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking STOP-ROP: is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP.
    Gaynon MW
    Retina; 2006 Sep; 26(7 Suppl):S18-23. PubMed ID: 16946672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors.
    Gaynon MW; Wong RJ; Stevenson DK; Sunshine P
    J Perinatol; 2018 Oct; 38(10):1295-1300. PubMed ID: 30046180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are there predictors for proliferative retinopathy of prematurity and is supplemental oxygen a useful conservative treatment option?].
    Müller H; Weiss C; Kuntz S; Akkoyun I; Schaible T
    Klin Padiatr; 2005; 217(2):53-60. PubMed ID: 15770574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolving our uncertainty about oxygen therapy.
    Cole CH; Wright KW; Tarnow-Mordi W; Phelps DL;
    Pediatrics; 2003 Dec; 112(6 Pt 1):1415-9. PubMed ID: 14654618
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
    Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
    Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study.
    VanderVeen DK; Coats DK; Dobson V; Fredrick D; Gordon RA; Hardy RJ; Neely DE; Palmer EA; Steidl SM; Tung B; Good WV;
    Arch Ophthalmol; 2006 Jun; 124(6):766-73. PubMed ID: 16769828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Dobson V; Quinn GE; Summers CG; Saunders RA; Phelps DL; Tung B; Palmer EA
    Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4236-44. PubMed ID: 8002243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Retinopathy of Prematurity (ROP).
    Dogra MR; Katoch D; Dogra M
    Indian J Pediatr; 2017 Dec; 84(12):930-936. PubMed ID: 28674824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fluctuation of oxygenation and time spent in the target range on retinopathy of prematurity in extremely low birth weight infants.
    Das A; Mhanna M; Sears J; Houdek JW; Kumar N; Gunzler D; Einstadter D; Collin M
    J Neonatal Perinatal Med; 2018; 11(3):257-263. PubMed ID: 30103354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SpO2 and retinopathy of prematurity: state of the art.
    Martinelli S; Gatelli I; Proto A
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():108-10. PubMed ID: 22958036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen targets for preterm infants.
    Stenson BJ
    Neonatology; 2013; 103(4):341-5. PubMed ID: 23736013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity in infants of <33 weeks gestation.
    Tokuhiro Y; Yoshida T; Nakabayashi Y; Nakauchi S; Nakagawa Y; Kihara M; Mitsufuji N; Kizaki Z
    Pediatr Int; 2009 Dec; 51(6):804-6. PubMed ID: 19419520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinopathy of prematurity.
    Engel RR; Oden NL; Cohen GR; Phelps DL;
    Paediatr Perinat Epidemiol; 2006 Jul; 20(4):348-59. PubMed ID: 16879508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.